Pet Cancer Therapeutics Market will register 10% CAGR to beat $300 million by 2024

Pet Cancer Therapeutics Market will register 10% CAGR to beat $300 million by 2024

UK pet cancer therapeutics market held largest regional share in 2016 and continue to grow at lucrative CAGR in coming years where Vaccines market is likely to witness strong growth owing to introduction of new vaccines over the forecast period

SELLBYVILLE, Del., April 23, 2018 /PRNewswire-iReach/ -- Global Pet Cancer Therapeutics Market is expected to surpass USD 300 million by 2024, as per a new research report by Global Market Insights, Inc. Growing pet adoption rate coupled with increasing disposable income of pet owners will drive pet cancer therapeutics market growth. Strong and robust drug pipeline for treatment of pet cancer will stimulate business growth over the forecast years.

High cost of pet cancer drugs along with rising instances of adverse drug events should hamper industry growth over the forecast years. Lack of awareness regarding pet diseases among the pet owners will impede industry expansion.

Chemotherapy has been the mainstream medication for pet cancers till recent times. However, immunological vaccines entered the market and are gaining significant market share. With number of chemotherapy drugs in pipeline, the industry should witness considerable growth over the coming years.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2017

Dogs are more prone to develop cancer than cats and the healthy pipeline will drive segment growth over the forecast years. However, introduction of specialized cat cancer medicines will stimulate the cat cancer therapeutics market growth.

Pet healthcare companies are focusing on development of drugs for mast cell cancer and melanoma among other cancer types. This trend will witness change as medicines to treat lymphoma and mammary cell cancer are in the pipeline. Innovative medicines for treatment of multiple cancer tumors is anticipated to accelerate business growth.

Browse key industry insights spread across 95 pages with 80 market data tables & 9 figures & charts from the report, "Pet Cancer Therapeutics Market" in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/pet-cancer-therapeutics-market

U.S. pet cancer therapeutics market holds the largest revenue share in 2016. Presence of large number of pet drug manufacturing companies, quick adoption of innovative pet care medicines and increasing disposable income of pet owners will boost industry growth.

Australia pet cancer therapeutics market held highest regional revenue share in 2016 owing to growing pet-keeping trend, availability of innovative pet care medicines and increasing disposable income of pet owners.

Some of the leading industry players include Zoetis, Merial, Aratana Therapeutics, AB Science, Vetivax, Oasmia Pharmaceutical, VetDC, Regeneus, CanFel Therapeutics, Karyopharms Verdinexor. The most commonly adopted business strategies by industry participants includes new product launches, regional expansion and mergers and acquisition.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2017

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Media Contact: Arun Hegde, Global Market Insights, Inc., +13028467766, sales@gminsights.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Global Market Insights, Inc.